96 related articles for article (PubMed ID: 9381783)
1. [Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use].
Böger RH; Bode-Böger SM
Vasa; 1997 Aug; 26(3):180-4. PubMed ID: 9381783
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects].
Böger RH; Bode-Böger SM; Frölich JC
Vasa; 1996; 25(4):305-16. PubMed ID: 9036707
[TBL] [Abstract][Full Text] [Related]
3. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
[TBL] [Abstract][Full Text] [Related]
4. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Junker W; Alexander K; Frölich JC
Circulation; 1997 Apr; 95(8):2068-74. PubMed ID: 9133517
[TBL] [Abstract][Full Text] [Related]
5. Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction.
Tsao PS; Cooke JP
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S48-53. PubMed ID: 9883748
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived factors and peripheral vascular disease.
Cooke JP
Cardiovasc Clin; 1992; 22(3):3-17. PubMed ID: 1600550
[TBL] [Abstract][Full Text] [Related]
7. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
[TBL] [Abstract][Full Text] [Related]
8. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
Tschudi MR; Lüscher TF
Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis.
Bode-Böger SM; Böger RH; Kielstein JT; Löffler M; Schäffer J; Frölich JC
J Investig Med; 2000 Mar; 48(2):125-32. PubMed ID: 10736972
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase: role in the genesis of vascular disease.
Cooke JP; Dzau VJ
Annu Rev Med; 1997; 48():489-509. PubMed ID: 9046979
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion.
Lüscher TF; Yang ZH; Diederich D; Bühler FR
J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S63-9. PubMed ID: 2478827
[TBL] [Abstract][Full Text] [Related]
12. Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans.
Engelberger RP; Pittet YK; Henry H; Delodder F; Hayoz D; Chioléro RL; Waeber B; Liaudet L; Berger MM; Feihl F
Shock; 2011 Jan; 35(1):28-34. PubMed ID: 20577147
[TBL] [Abstract][Full Text] [Related]
13. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
Michel JB
Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and atherosclerosis.
Napoli C; Ignarro LJ
Nitric Oxide; 2001 Apr; 5(2):88-97. PubMed ID: 11292358
[TBL] [Abstract][Full Text] [Related]
15. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
16. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and atherosclerotic lesion progression: an overview.
Napoli C
J Card Surg; 2002; 17(4):355-62. PubMed ID: 12546087
[TBL] [Abstract][Full Text] [Related]
18. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects.
Schlaich MP; Parnell MM; Ahlers BA; Finch S; Marshall T; Zhang WZ; Kaye DM
Circulation; 2004 Dec; 110(24):3680-6. PubMed ID: 15569830
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal endothelium-mediated regulation of vascular tone in arteriosclerosis].
Mügge A
Z Kardiol; 1994 Oct; 83(10):759-67. PubMed ID: 7528959
[TBL] [Abstract][Full Text] [Related]
20. Possible role of adenosine deaminase in vaso-occlusive diseases.
Jackson EK; Koehler M; Mi Z; Dubey RK; Tofovic SP; Carcillo JA; Jones GS
J Hypertens; 1996 Jan; 14(1):19-29. PubMed ID: 12013490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
